Schonfeld Strategic Advisors’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $647K | Buy |
99,590
+34,065
| +52% | +$221K | ﹤0.01% | 1379 |
|
|
2025
Q1 | $520K | Buy |
+65,525
| New | +$520K | ﹤0.01% | 1446 |
|
|
2024
Q4 | – | Sell |
-47,380
| Closed | -$660K | – | 1988 |
|
|
2024
Q3 | $660K | Sell |
47,380
-197,577
| -81% | -$2.75M | ﹤0.01% | 1181 |
|
|
2024
Q2 | $3.38M | Buy |
244,957
+7,209
| +3% | +$99.3K | 0.02% | 592 |
|
|
2024
Q1 | $3.93M | Buy |
237,748
+58,814
| +33% | +$972K | 0.03% | 608 |
|
|
2023
Q4 | $2.61M | Buy |
178,934
+42,234
| +31% | +$617K | 0.02% | 654 |
|
|
2023
Q3 | $1.68M | Buy |
136,700
+21,182
| +18% | +$260K | 0.01% | 762 |
|
|
2023
Q2 | $1.38M | Buy |
115,518
+10,578
| +10% | +$126K | 0.01% | 868 |
|
|
2023
Q1 | $1.4M | Sell |
104,940
-10,560
| -9% | -$141K | 0.01% | 799 |
|
|
2022
Q4 | $2.49M | Buy |
115,500
+92,113
| +394% | +$1.98M | 0.02% | 735 |
|
|
2022
Q3 | $468K | Sell |
23,387
-16,913
| -42% | -$338K | ﹤0.01% | 1773 |
|
|
2022
Q2 | $722K | Buy |
+40,300
| New | +$722K | 0.01% | 1097 |
|